Table 1 Pilgrims’ socio-demographics, medical history and vaccination status (n = 510)
Characteristic | n (%) |
|---|---|
Age (years) | |
 18–25 | 55 (10.8) |
 26–39 | 109 (21.3) |
 40–55 | 209 (41) |
 56–64 | 127 (24.9) |
 ≥ 65 | 10 (2) |
Gender | |
 Male: female | 230: 280 (45:55) |
Nationality | |
 Saudi Arabia | 437 (85.7) |
 Egypt | 28 (5.5) |
 Yemen | 8 (1.6) |
 Tunis | 4 (0.8) |
 Syria | 4 (0.8) |
 Sudan | 4 (0.8) |
 Others | 25 (4.8) |
Education | |
 No education | 9 (1.8) |
 Primary/elementary school certificate | 20 (3.9) |
 High school certificate | 64 (12.5) |
 Diploma | 27 (5.3) |
 Bachelor’s certificate | 276 (54.1) |
 Higher university degree | 114 (22.4) |
Occupation | |
 Unemployed | 107 (21.0) |
 Student | 31 (6.1) |
 Retired | 94 (18.4) |
 Public sector worker | 126 (24.7) |
 Private sector worker | 120 (23.5) |
 Self-employed | 32 (6.3) |
Presence of chronic medical conditions | |
 Hypertension | 66 (12.9) |
 Diabetes | 46 (9.0) |
 Obesity | 19 (3.7) |
 Chronic lung disease | 19 (3.7) |
 Chronic heart disease | 10 (2.0) |
Smoking status | |
 Non-smoker | 375 (73.5) |
 Current smoker | 77 (15.1) |
 Past smoker | 37 (7.3) |
 Passive smoker | 21 (4.1) |
Received influenza (flu) vaccine | |
 No | 213 (41.8) |
 Yes | 297 (58.2) |
Received first dose of COVID-19 vaccine | |
 Oxford/AstraZeneca | 98 (19.2) |
Pfizer | 410 (80.4) |
Moderna | 1 (0.2) |
Received second dose of COVID-19 vaccine | |
 Oxford/AstraZeneca | 38 (7.5) |
 Pfizer | 433 (84.8) |
 Moderna | 1 (0.2) |
Reported COVID-19 vaccine adverse reactions | |
 Pain/redness at injection site | 149 (29.2) |
 Fatigue and headache | 153 (30) |
 Muscle pain | 123 (24.1) |
 Fever/chills | 116 (22.7) |
 Difficulty in breathing | 5 (1) |
 Nausea/vomiting | 5 (1) |
 Diarrhoea | 7 (1.4) |